Clinical Trial Update: Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients [Phase 4]

View source ↗

Summary

Clinical trial update describes Phase 4 evaluation of pharmacogenetics-guided warfarin dosing in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Pulmonary Embolism
• Valvular Heart Disease

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Atrial Fibrillation, Deep Vein Thrombosis | Phase 4 | Status: UNKNOWN